He earned his professional degrees from Yale University and completed his post-doctoral program and neurology residency at the University of California San Francisco. He heads up The Cooper Laboratory for molecular neuropharmacology at Baylor. His RIKEE project, a multicenter patient registry to study KCNQ2 variants and characteristics, is headquartered there.